- Home
- TPVG vs CADL Comparison
TPVG vs CADL Comparison
Compare TPVG & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPVG
- CADL
- Stock Information
- Founded
- TPVG 2013
- CADL 1999
- Country
- TPVG United States
- CADL United States
- Employees
- TPVG N/A
- CADL N/A
- Industry
- TPVG Other Consumer Services
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- TPVG Consumer Discretionary
- CADL Health Care
- Exchange
- TPVG Nasdaq
- CADL Nasdaq
- Market Cap
- TPVG 273.2M
- CADL 313.5M
- IPO Year
- TPVG N/A
- CADL 2021
- Fundamental
- Price
- TPVG $6.63
- CADL $5.82
- Analyst Decision
- TPVG Hold
- CADL Strong Buy
- Analyst Count
- TPVG 5
- CADL 5
- Target Price
- TPVG $6.75
- CADL $21.40
- AVG Volume (30 Days)
- TPVG 401.3K
- CADL 582.4K
- Earning Date
- TPVG 08-06-2025
- CADL 08-14-2025
- Dividend Yield
- TPVG 13.90%
- CADL N/A
- EPS Growth
- TPVG N/A
- CADL N/A
- EPS
- TPVG 1.03
- CADL N/A
- Revenue
- TPVG $97,395,000.00
- CADL N/A
- Revenue This Year
- TPVG N/A
- CADL N/A
- Revenue Next Year
- TPVG $6.13
- CADL N/A
- P/E Ratio
- TPVG $6.43
- CADL N/A
- Revenue Growth
- TPVG N/A
- CADL N/A
- 52 Week Low
- TPVG $5.53
- CADL $3.79
- 52 Week High
- TPVG $8.50
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- TPVG 51.11
- CADL 45.80
- Support Level
- TPVG $6.02
- CADL $5.69
- Resistance Level
- TPVG $6.70
- CADL $6.18
- Average True Range (ATR)
- TPVG 0.15
- CADL 0.32
- MACD
- TPVG 0.05
- CADL -0.03
- Stochastic Oscillator
- TPVG 85.04
- CADL 35.92
About TPVG TriplePoint Venture Growth BDC Corp.
TriplePoint Venture Growth BDC Corp is a closed-end, non-diversified management investment company. Its investment objective is to maximize its total return to stockholders in the form of current income and, to a lesser extent, capital appreciation. The fund focuses on companies operating in the fields of biofuels, business applications software, wireless communications equipment, e-commerce, clothing and accessories, conferencing equipment and services, personal goods, financial institutions and services, entertainment, mixed retailing, and healthcare services. Geographically, all the operations of the firm function through the region of the United states.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.